IBSA USA
Don Bassham is an experienced sales professional with a comprehensive background in specialty sales and account management across various industries, particularly in the energy and pharmaceutical sectors. Currently serving as a Specialty Sales Representative at IBSA USA since June 2023, Don has previously held significant positions at Straitline Well Services, Stuart Pressure Control, and Select Energy Services, where expertise in corporate sales and the initiation of sales strategies for various service lines has been demonstrated. Don's pharmaceutical experience includes positions with Novartis and Pfizer, where robust sales achievements, including numerous contests and market share increases, were secured. Don holds a B.S. in Kinesiology from the University of Houston.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.